SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Taki who wrote (132050)4/28/2004 3:59:40 PM
From: Taki  Read Replies (1) of 150070
 
DNAP.042.Good news 15 minutes ago.PR NEWSWIRE) DNAPrint's DNAWitness(TM) Technology Tightens Net on UK Rapist
DNAPrint's DNAWitness(TM) Technology Tightens Net on UK Rapist

SARASOTA, Fla., April 28 /PRNewswire-FirstCall/ -- DNAPrint genomics
(OTC Bulletin Board: DNAP) (DNAP) of Sarasota, FL confirmed that the United
Kingdom's New Scotland Yard and London's Metropolitan Police have
strategically employed its proprietary DNAWitness(TM) test.
The genomics test was used as part of a 12-year investigation focused on a
serial rapist who has committed over 80 attacks on mostly elderly victims.
The case is still unresolved. Ongoing research at DNAPrint(TM) has resulted
in a substantial enhancement of the power of DNAWitness(TM) as an
investigative tool.
Metropolitan Police Detectives said the test gave them their biggest lead
yet in a 12-year hunt for a serial sex attacker who preys on elderly women.
"After 12 years we feel this is a major breakthrough and are confident that
the new DNA results should lead us to the suspect or even his relatives,"
Detective Superintendent Simon Morgan of London's Metropolitan Police told
reporters on Tuesday.
For the full story see: uk.news.yahoo.com.
"Earlier this year we announced our new product, DNAWitness(TM), and since
then the product has been used on nearly 40 cases," said Richard Gabriel, CEO
and President of DNAPrint(TM). "The fact is that we are not permitted to
discuss any of these cases with the media, and so the importance of our
contributions often goes unnoticed by the public. When a particular group
such as the London Metropolitan Police and New Scotland Yard give us
permission to discuss our involvement, it should signal to the rest of the law
enforcement community, worldwide, that DNAWitness(TM) is a viable source of
new information on crimes," he said.
As a presumptive test, DNAWitness(TM) can be used on other crimes such as
burglary, robbery, assault, battery, murder and other felony crimes -- as long
as a biological specimen (such as blood, semen, saliva or hair) was left at
the scene. Florida had 26,000 aggravated rapes last year, and samples were
collected from most every one, but the samples sit on shelves for years when
they could be used to paint profiles of the rapists. DNAPrint(TM) would like
every patrol car in the near future to carry a DNAWitness(TM) crime scene kit.
Mr. Gabriel continued, "Patterns could be uncovered, eye-witness leads
prioritized, and social and geographical links established that might lead to
apprehensions, and prevent further harm to unsuspecting individuals. However,
most states do not use their resources to even process these kits for standard
(low tech) DNA testing, which is always the first DNA test performed. Those
that do use our technology in the U.S. are often prevented from publicizing
their profiles. This is unfortunate because publication of the profile often
results in new leads. We have learned that there are countless frustrated
and hard working investigators that want to use our new technology but don't
have the funds available to them, and who want to publicize their profiles but
cannot. Law enforcement and prosecutors now have additional tools to hunt
down and jail these criminals, and it would be in all of our interests that
they be more widely used. DNAWitness(TM) is not a panacea, but it is another
tool, and it's available now. And that new tool, coupled with good old
fashioned detective work, will help get repeat offenders off our streets."

About DNAPrint genomics, Inc.
DNAPrint genomics Inc. uses proprietary human genome research methods to
develop genomic-based services and products. The Company introduced
ANCESTRYbyDNA(TM) in the consumer market and DNAWitness(TM) in the forensic
market in 2003. DNAPrint(TM) is developing products in the pharmacogenomic
market and has a disease gene discovery program. The Company is traded on the
Nasdaq OTC Bulletin Board under the ticker symbol: DNAP. For more information
about the company, please visit www.dnaprint.com.
DNAWitness(TM) is a DNAPrint genomics, Inc. proprietary product and FREE
collection kits can be ordered from Lynn Peavey - crime scene supplies
Forensic Innovations for Law Enforcement and Laboratories 1-800-255-6499,
800-255-6499 (C) Copyright 2003 Lynn Peavey Company.
lynnpeavey.com or from DNAPrint(TM) directly
1-941-366-3400 dnaprint.com.

All statements in this press release that are not historical are forward-
looking statements within the meaning of Section 21E of the Securities
Exchange Act as amended. Such statements are subject to risks and
uncertainties that could cause actual results to differ materially from those
projected, including, but not limited to, uncertainties relating to
technologies, product development, manufacturing, market acceptance, cost and
pricing of DNAPrint's products, dependence on collaborations and partners,
regulatory approvals, competition, intellectual property of others, and patent
protection and litigation. DNAPrint genomics, Inc. expressly disclaims any
obligation or undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change in
DNAPrint's expectations with regard thereto or any change in events,
conditions, or circumstances on which any such statements are based.

Media and Press Contacts
Richard Gabriel
DNAPrint Genomics, Inc.CEO/President(941) 366-3400

SOURCE DNAPrint Genomics, Inc.
-0- 04/28/2004
/CONTACT: Richard Gabriel, CEO and President, DNAPrint Genomics,
+1-941-366-3400/
/Web site: dnaprint.com /
(DNAP)

CO: DNAPrint Genomics, Inc.
ST: Florida
IN: MTC OTC
SU:
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext